Despite these hurdles, the study demonstrated that CD33-deleted HSPCs could successfully engraft and resist CAR33-mediated depletion, highlighting the potential of gene editing to enhance stem cell ...
Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...
PHILADELPHIA, March 19, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell ...
When Nasa astronaut Sunita 'Suni' Williams, 59, returned to Earth this week, after being stranded in space for 288 days, the ...
A dermatologist has insisted there's nothing to worry about if you have noticed strange patches in your grey hairs – as it just means one change is happening to your body ...
What if your child's epic tantrums aren't your fault - or theirs? What if the reason they struggle to sleep, act up around ...
A research team has, for the first time in the world, revealed the identity and differentiation process of human cervical ...
Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...
A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal cord injury. The ...
Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...
Activating stem cells via molecular programming, rather than relying on random cell transplants, significantly enhances the success of regenerative treatments.
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback